CSCIED

期刊目次

加入编委

期刊订阅

添加您的邮件地址以接收即将发行期刊数据:

Open Access Article

International Journal of Clinical Research. 2024; 8: (5) ; 66-68 ; DOI: 10.12208/j.ijcr.20240178.

Analysis of common complications in medical oncology and discussion of treatment strategies
肿瘤内科治疗常见并发症的分析及治疗对策探讨

作者: 张莹莹 *

呼伦贝尔市第二人民医院(呼伦贝尔市传染病医院) 内蒙古呼伦贝尔

*通讯作者: 张莹莹,单位:呼伦贝尔市第二人民医院(呼伦贝尔市传染病医院) 内蒙古呼伦贝尔;

发布时间: 2024-05-20 总浏览量: 146

摘要

目的 肿瘤一般分为良性肿瘤和恶性肿瘤,恶性肿瘤俗称癌症,可在人体全身发病,但无传染性,是100多种相关疾病的统称,严重影响人们的身体健康甚至威胁生命,应给予及时有效的治疗,但在治疗过程中常会伴随一系列的并发症,因此本文探析肿瘤内科治疗常见并发症的分析及治疗对策。方法 选取在我院肿瘤内科接受治疗的肿瘤患者作为研究对象,分析患者治疗期间的常见并发症,并制定相应的治疗对策。结果 观察组并发症发生率、心理状态及治疗满意度和生活质量评分均优于对照组,P<0.05,说明存在对比意义。结论 对肿瘤患者实施肿瘤内科治疗时,应通过细致的观察、及时的处理和个性化的治疗,最大限度地降低并发症,以确保治疗效果,进而改善患者生存质量。

关键词: 肿瘤内科治疗;常见并发症;治疗对策

Abstract

Objective Tumors are generally divided into benign tumors and malignant tumors, malignant tumors commonly known as cancer, can occur in the body, but not infectious, is the collective name of more than 100 related diseases, seriously affect people's health and even threaten life, should be given timely and effective treatment, but in the treatment process is often accompanied by a series of complications, Therefore, this article analyzes the common complications of medical oncology treatment and the treatment countermeasures.
Methods The patients who received treatment in the Department of Oncology of our hospital were selected as the study objects, the common complications of patients during treatment were analyzed, and the corresponding treatment strategies were formulated.
Results The incidence of complications, psychological state, treatment satisfaction and quality of life in the observation group were better than those in the control group (P < 0.05), indicating comparative significance.
Conclusion   Careful observation, timely treatment and personalized treatment should be used to minimize complications, so as to ensure the therapeutic effect and improve the quality of life of patients.

Key words: Medical treatment of cancer; Common complications; Treatment strategy

参考文献 References

[1] 勾贺,孟宇,宋敏.神经内分泌肿瘤内科治疗的研究进展[J].河南医学研究,2019(9):1727-1728.

[2] 梁振雄,王若天,符敏,等.贝伐珠单抗联合XELOX化疗对结直肠癌疗效、血清CRP水平及生存时间的影响[J].实用癌症杂志,2020,35(2):326-329.

[3] 李文,米玉玲.聚乙二醇化重组人粒细胞刺激因子对恶性肿瘤化疗后中性粒细胞减少症预防效果的影响因素[J].大医生,2021,6(13):109-111.

[4] 吴俊.恶性肿瘤患者肿瘤内科治疗中的并发感染临床研究[J].中国科技期刊数据库 医药,2022(9):0079-0082.

[5] 姜丽,高丽华,周振宇.肿瘤内科治疗常见并发症感染的观察处理[J].中国现代药物应用,2021,5(10):46-47.

[6] 孔令海,王保利,赵晓雷.肿瘤内科治疗并发症处理的临床体会[J].世界最新医学信息文摘,2019(04):97,15

[7] 田海军.肿瘤内科患者并发症的临床治疗效果分析[J].智慧健康,2020,6(13):157-158.

[8] 韩志勇,左刚,王健.肿瘤内科化疗患者常见并发症及其处理对策[J].临床医药文献电子杂志,2019,334(17):92-100.

引用本文

张莹莹, 肿瘤内科治疗常见并发症的分析及治疗对策探讨[J]. 国际临床研究杂志, 2024; 8: (5) : 66-68.